Drugs / Glimepirde
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT02338921 Comparator | Jan 2015 → Nov 2021 | type 2 diabetes mellitus | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| — | NCT05261997 Background | Mar 2022 → Nov 2023 | chronic pancreatitis, exocrine pancreatic insufficiency | Changhai Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glimepirde | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02338921 ↗ |